An Assessment of an Outpatient Antimicrobial Therapy Program in a Rural Medical Center : A Retrospective Chart Review

Critical Care Nursing Quarterly
Matthew Shawn BurkettAnthony Knight

Abstract

Current literature supports outpatient parenteral antimicrobial therapy (OPAT). This article presents results from a research study that evaluated an OPAT program that treated community-acquired pneumonia. If patients had the opportunity to receive outpatient intravenous antibiotics for community-acquired pneumonia, would this prevent future hospitalization? Was there a decrease in hospital admissions? An informal cost-benefit analysis comparing OPAT with inpatient hospital admissions for the same disease was also reviewed to provide evidence whether there was a change. What was the overall health care cost savings? The medical charts of 50 patients with confirmed pneumonia who had received OPAT in a 3-month period were reviewed. A retrospective medical record review was performed. All patients were evaluated by the in-house OPAT team. The resulting analysis provided evidence that an estimated savings of approximately $2100 per day would be achieved by decreasing hospital readmissions for patient who had been treated with OPAT. The conclusion of this study provides evidence that the implement of an OPAT program was, and is, essential for patient care and evidence-based best practice adherence.

References

Jan 1, 1991·Reviews of Infectious Diseases·A D Tice
Mar 1, 1996·Annals of Emergency Medicine·E H GilbertJ Steiner
Sep 16, 1998·Clinical Therapeutics·M S NiedermanR Popovian
Jan 15, 1999·Infectious Disease Clinics of North America·B R Nolet
Feb 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lionel A MandellUNKNOWN American Thoracic Society
Jun 10, 2009·Current Opinion in Infectious Diseases·Charis Marwick, Peter Davey
Sep 22, 2009·The Journal of Antimicrobial Chemotherapy·Ann L N ChapmanJulie D Patchett
Sep 3, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mobeen H Rathore
Sep 3, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Barbara Ross Nolet
Sep 3, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hien H Nguyen
Apr 11, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Eavan G MuldoonGeneve M Allison

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
E M PsaltikidisM R Resende
Clinical Medicine : Journal of the Royal College of Physicians of London
D A Barr, R A Seaton
Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine
Alison M BeielerJohn B Lynch
© 2022 Meta ULC. All rights reserved